Your browser doesn't support javascript.
loading
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.
Procopio, Giuseppe; Apollonio, Giulia; Cognetti, Francesco; Miceli, Rosalba; Milella, Michele; Mosca, Alessandra; Chiuri, Vincenzo Emanuele; Bearz, Alessandra; Morelli, Franco; Ortega, Cinzia; Atzori, Francesco; Donini, Maddalena; Ratta, Raffaele; Raimondi, Alessandra; Claps, Melanie; Martinetti, Antonia; Capitanio, Umberto; de Braud, Filippo G; Cappelletti, Vera; Verzoni, Elena.
Afiliación
  • Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: giuseppe.procopio@istitutotumori.mi.it.
  • Apollonio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cognetti F; Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy.
  • Miceli R; Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Milella M; Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy.
  • Mosca A; Department of Oncology, Maggiore Della Carità University Hospital, Novara, Italy.
  • Chiuri VE; Medical Oncology Department, Ospedale Vito Fazzi, Lecce, Italy.
  • Bearz A; Medical Oncology Department, National Cancer Institute, Aviano, Italy.
  • Morelli F; Medical Oncology Department, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Ortega C; Medical Oncology Department, Istituto per la Ricerca e la Cura del Cancro di Candiolo, Torino, Italy.
  • Atzori F; Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy.
  • Donini M; Medical Oncology Department, Ospedale di Cremona, Cremona, Italy.
  • Ratta R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Raimondi A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Claps M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Martinetti A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Capitanio U; Division of Experimental Oncology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.
  • de Braud FG; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Cappelletti V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Verzoni E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Eur Urol Oncol ; 2(6): 699-707, 2019 11.
Article en En | MEDLINE | ID: mdl-31542243
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Carcinoma de Células Renales / Metastasectomía / Sorafenib / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Eur Urol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Carcinoma de Células Renales / Metastasectomía / Sorafenib / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Eur Urol Oncol Año: 2019 Tipo del documento: Article